Indiana University Health University Hospital is a teaching hospital in Indianapolis, Indiana, United States, affiliated with the Indiana University School of Medicine and Indiana University Health.

During the past decade, Indiana University Health conducted 53 clinical trials. In the 10-year time frame, 53 clinical trials started and 17 clinical trials were completed, i.e. on average, 32.1% percent of trials that started reached the finish line to date. In the past 5 years, 21 clinical trials started and 11 clinical trials were completed. i.e. 52.4% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Indiana University Health" #1 sponsor was "Indiana University" with 17 trials, followed by "Bristol-Myers Squibb" with 7 trials sponsored, "Eli Lilly and Company" with 6 trials sponsored, "Boston Scientific Corporation" with 3 trials sponsored and "Aerovate Therapeutics" with 3 trials sponsored. Other sponsors include 35 different institutions and companies that sponsored additional 43 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Indiana University Health" #1 collaborator was "Indiana University Health" with 4 trials as a collaborator, "National Institute on Aging (NIA)" with 4 trials as a collaborator, "National Institutes of Health (NIH)" with 3 trials as a collaborator, "University of Michigan" with 3 trials as a collaborator and "National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)" with 2 trials as a collaborator. Other collaborators include 42 different institutions and companies that were collaborators in the rest 49 trials.

According to Clinical.Site data, the most researched conditions in "Indiana University Health" are "Pulmonary Arterial Hypertension" (4 trials), "Crohn's Disease" (3 trials), "Hepatitis C" (3 trials), "Pancreatic Cancer" (3 trials) and "Anxiety" (2 trials). Many other conditions were trialed in "Indiana University Health" in a lesser frequency.

Most popular intervention types in "Indiana University Health" are "Drug" (34 trials), "Device" (12 trials), "Other" (8 trials), "Behavioral" (7 trials) and "Procedure" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (13 trials), "Mirikizumab" (3 trials), "AV-101" (2 trials), "Baricitinib" (2 trials) and "DCV/ASV/BMS-791325" (2 trials). Other intervention names were less common.

The vast majority of trials in "Indiana University Health" are 72 trials for "All" genders, 2 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Indiana University Health". 1 are not yet recruiting, 15 are recruiting, 7 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 42 completed trials in Indiana University Health, undefined suspended trials, and 7 terminated clinical trials to date.

Out of the total trials that were conducted in Indiana University Health, 3 "Phase 1" clinical trials were conducted, 18 "Phase 2" clinical trials and 21 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 19 trials that are defined as “Not Applicable".